PIERIS PHARMACEUTICALS
Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin® technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need. Anticalins are recombinantly engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. Our libraries of more than 100 billion different Anticalins can virtually bind to any target of interest.
PIERIS PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2001-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.pieris.com
Total Employee:
101+
Status:
Active
Contact:
+118572468998
Email Addresses:
[email protected]
Total Funding:
160 M USD
Technology used in webpage:
Domain Not Resolving Google Maps HSTS Organization Schema Google Adsense Place Schema JobPosting Schema Amazon Singapore Region Colt
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
KBP Biosciences
A multinational clinical stage biotechnology company.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Reviva Pharmaceuticals
Reviva Pharmaceuticals is a clinical-stage pharmaceutical company developing innovative therapies.
Selecta Biosciences
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Seagen
Seagen investment in Post-IPO Equity - Pieris Pharmaceuticals
Aquilo Capital Management
Aquilo Capital Management investment in Post-IPO Equity - Pieris Pharmaceuticals
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Pieris Pharmaceuticals
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Pieris Pharmaceuticals
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Pieris Pharmaceuticals
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Pieris Pharmaceuticals
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Pieris Pharmaceuticals
Ally Bridge Group
Ally Bridge Group investment in Post-IPO Equity - Pieris Pharmaceuticals
Montrose Capital Partners
Montrose Capital Partners investment in Post-IPO Equity - Pieris Pharmaceuticals
Lombard Odier
Lombard Odier investment in Post-IPO Equity - Pieris Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.pieris.com Semrush global rank: 7.37 M Semrush visits lastest month: 801
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Pieris Pharmaceuticals"
Pieris Pharmaceuticals - Crunchbase Company Profile & Funding
Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin® technology to create differentiated drugs that can help patients suffering from …See details»
Pieris Pharmaceuticals Provides Strategic Update and Announces ...
Jul 18, 2023 In December 2024, Pieris Pharmaceuticals merged with Palvella Therapeutics, Inc. Palvella Therapeutics (Nasdaq: PVLA), is a clinical-stage biopharmaceutical company focused …See details»
Pieris AG - Crunchbase Company Profile & Funding
Pieris Pharmaceuticals is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and other medical conditions with unmet medical needs. The …See details»
Pieris Pharmaceuticals Org Chart + Executive Team - The Official …
Organizational Chart of Pieris Pharmaceuticals. Pieris Pharmaceuticals Org Chart www.pieris.com. has 11 executives +1 857 246 8998; Add an executive. Pieris …See details»
Pieris Pharmaceuticals - The Org
Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and …See details»
Pieris Pharmaceuticals, Inc. - AnnualReports.com
Pieris is a clinical-stage biotechnology company that discovers and develops Anticalin protein-based drugs to target validated disease pathways in a unique and transformative way. Our …See details»
Pieris Pharmaceuticals - Gilde Healthcare
Pieris Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the discovery and development of its proprietary Anticalin® class of biotherapeutics. The company has …See details»
Management Team :: Pieris Pharmaceuticals, Inc. (PIRS)
In December 2024, Pieris Pharmaceuticals merged with Palvella Therapeutics, Inc. Palvella Therapeutics (Nasdaq: PVLA), is a clinical-stage biopharmaceutical company focused on …See details»
Pieris - VentureRadar
Pieris AG is a biopharmaceutical company engaged in the discovery and development of Anticalins® for the diagnosis and treatment of life-threatening human disorders. Exploiting …See details»
Pieris Pharmaceuticals - Craft
Oct 29, 2024 Pieris Pharmaceuticals is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. The Company's …See details»
Board of Directors :: Pieris Pharmaceuticals, Inc. (PIRS)
Mr. Geraghty joined the Board of Directors of Pieris in May 2017 and was appointed as Pieris’ Chairman of the Board of Directors in December 2017. Mr. Geraghty is an industry leader with …See details»
Pieris Pharmaceuticals - Overview, News & Similar companies
May 22, 2024 Pieris Pharmaceuticals contact info: Phone number: (857) 246-8998 Website: www.pieris.com What does Pieris Pharmaceuticals do? Founded in 2000 and headquartered …See details»
Pieris Pharmaceuticals - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Pieris Pharmaceuticals (USA) Funding: $160M - Medical Startups
Apr 2, 2025 Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and …See details»
Pieris Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Pieris Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 19 clinical trials, 65 news, and 19 literature, Disease Domain:Neoplasms, Endocrinology and …See details»
Pieris Pharma (PIRS) Provides Strategic Update and Announces …
Jul 18, 2023 Pieris' management and board of directors have assessed several strategic options, which will include focusing on execution of new or expanded partnerships to advance …See details»
GEBIS and 1 Buddhist monk told to pay $110,000 after fatal
23 hours ago Meanwhile the organization will pay $15,000 in fines for its three OHS charges and $85,000 to the board. ABOUT THE AUTHOR. Nicola MacLeod. Video Journalist.See details»
Pipeline :: Pieris Pharmaceuticals, Inc. (PIRS)
In December 2024, Pieris Pharmaceuticals merged with Palvella Therapeutics, Inc. Palvella Therapeutics (Nasdaq: PVLA), is a clinical-stage biopharmaceutical company focused on …See details»
Annual Report - Pieris Pharmaceuticals, Inc.
PIERIS PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Nevada EIN 30-0784346 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer …See details»
Pieris Pharmaceuticals and Servier Announce Dosing of First …
Nov 8, 2021 BOSTON, MA and PARIS, FRANCE / ACCESSWIRE / November 8, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing …See details»